The week at Retraction Watch featured doubts about the effects of oxytocin, aka the “love hormone,” and a report on how common reference errors are. Here’s what was happening elsewhere, with apologies for the later-than-usual posting: A major success story drug for the NIH’s National Center for Advancing Translational Sciences may have downplayed problems in its … Continue reading Weekend reads: Questions about NIH success story; do Nobels need a reset?; coercing PhD graduates